What really caught my eye is that the longest implanted patient has had it for NINE YEARS!
Does that not speak to Vbloc's effectiveness?
If you go to the Foundry website you'll notice one of the investors is Kaiser Permanente, fanatic about adopting new procedures that save them long-term costs. Knudson specifically mentioned Kaiser for its cost sharing program in his 8/13 Canaccord presentation!
The run on independent transcatheter mitral valve replacement companies is now resembling a stampede thanks to Medtronic's ($MDT) decision to purchase Twelve, a portfolio company of medical device incubator The Foundry, for up to $458 million.
In fact, Twelve's clinical trial posting on ClinicalTrials.Gov is one of the few footprints left behind by the secretive company, which does not even have its own website. As of April, the 10-person trial had a primary completion date of September 2016, meaning final data collection for the primary outcome measure (the number of adverse events), is due by then.
deuxtrends: The number of clinics signed up just through early August is DOUBLE what ETRM projected for the whole year. Knudson in his Canaccord presentation pointed out that the company has met or exceeded all their statement following FDA approval. Your criticisms are 6-12 months too early. Hancock is doing a fine job.
Anyone who bought ETRM at the open or hundreds of other stocks are smiling. The U S stock markets are nearly always stronger than foreign markets.
deuxtrends: Nice try at misinformation. The truth is that ETRM has far exceeded the number of sign up clinics they projected six months ago. Number of clinics does eventually translate into demand. Many clinics are affiliated with hospitals or chains or at least have admitting privileges. Every new procedure has to be approved by a hospital committee comprised of medical professionals and at least one counsel. This varies greatly from state to state. In the case of a lawsuit EVERBODY gets sued.
pharma: That's why I have been loading up on shares below 25 cents. I would not be surprised if the three Medstar clinics in Washington/Baltimore metro area became top Vbloc volume achievers. I'd love to see a competition between the doctors at each clinic on who can do the most Vbloc implants in 2015-2016! Those of a certain age may remember when Houston heart surgeons Michael DeBakey and Denton Cooley had a fierce competition for patients.
Let the competition begin at Medstar. Their metro area has a huge pool of candidates with government and defense-private industry health coverage.
Brings my average down to .4555 on 69,104 shares. ETRM is adding centers much faster than they anticipated, with Medstar providing 3 clinics in the huge Wash-Balto market. An additional CE mark could come anytime now for hypertension. Don't be surprised to see more insider purchases(unless the window is closed) or aggressive small funds taking predatory positions.
Medstar just added a second and third Vbloc clinic in Baltimore and Washington. There are different surgeons for each center, not just one running back and forth.
Finally, overweight bureaucrats and government employees with great health coverage will do us some good!
question: Probably, as my understanding from the CC was that just over 50% of the 51 centers had received their hospital or hospital-affiliated approval to do Vbloc implants (that accounts for only 27 centers on the surgeon locater being listed-they only list centers approved to go). I would speculate that Cleveland and Mayo clinics will pop up on the surgeon locator by September.
There are a huge number of govt employes in Balt/Wash, nearly all of them covered by health plans that should approve Vbloc.
Murfee: I pointed out blatant errors in Spencer's report. Your reply was knee jerk. BTW, ETRM said after FDA approval that the rollout would be gradual.
1)Spencer does not correct his previous post about a 90-day grace period, just now says 180days; 2) idiotic mention that ETRM has to be above $1 for 10 trading days BEFORE grace period ends. Not true, NASDQ would grant an automatic tension on appeal if ETRM was above $1, no matter how many trading days; 3) His harping on ETRM "hiding something" because they only report sales, not unit sales! Duh, avg unit implant sale for 3rd qtr was $15,800 ($79K/5 units). This is like saying international weather reports are "hiding something" because they only report temperatures in Celsius!
Spencer is one lazy dud.
I added 3504 shares @.2416 on Wednesday for a total of 56,304 shares at avg cost around .50; will buy more if there is another dip. Other executives and board members need to buy shares.
Per Knudson just over 50% of the 51 centers have gone through hospital approval, which equates to the approx. 27 centers listed on the website. Several centers were listed and then withdrawn, probably awaiting hospital ok. That accounts for U C Irvine and Cleveland Clinic, Weston FL being prematurely listed. I would think there is a high possibility that Vbloc has Mayo clinic surgeons applying for hospital approval.
Wow! First time Knudson has mentioned Kaiser, which is a big player out here in California. Kaiser Permanente has an army of bean counters that can approve procedures that cut down on hospital admissions due to complications.